DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Gnant M, Pfeiler G, Steger GG. et al.
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, doubleblind, placebo-controlled, phase 3 trial.
Lancet Oncol 2019;
20: 339-351
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.